Publikationen in Zusammenarbeit mit Forschern von Fundación Jiménez Díaz (120)

2024

  1. Identifying COPD patients with poor health status and low exercise tolerance through the five-repetition sit-to-stand test and modified Medical Research Council Dyspnea Score

    European Journal of Internal Medicine, Vol. 125, pp. 51-56

  2. Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience

    Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 10-15

  3. Phosphodiesterase-5 Expression in Buccal Mucosa of Patients with Erectile Dysfunction One Year after Radical Prostatectomy

    Journal of Personalized Medicine, Vol. 14, Núm. 8

2023

  1. Toxicity of Asciminib in Real Clinical Practice: Analysis of Side Effects and Cross-Toxicity with Tyrosine Kinase Inhibitors

    Cancers, Vol. 15, Núm. 4

2022

  1. ANTES Program: One Year on

    Archivos de Bronconeumologia

  2. Effectiveness and Safety of Inhaled Antibiotics in Patients With Chronic Obstructive Pulmonary Disease. A Multicentre Observational Study

    Archivos de Bronconeumologia, Vol. 58, Núm. 1, pp. 11-21

  3. Real-life analysis on safety and efficacy of asciminib for ponatinib pretreated patients with chronic myeloid leukemia

    Annals of Hematology, Vol. 101, Núm. 10, pp. 2263-2270

2021

  1. Bronchial Thermoplasty Global Registry (BTGR): 2-year results

    BMJ Open, Vol. 11, Núm. 12

  2. Mortality rate in rheumatoid arthritis-related interstitial lung disease: the role of radiographic patterns

    BMC Pulmonary Medicine, Vol. 21, Núm. 1

  3. Natural Course of the Diffusing Capacity of the Lungs for Carbon Monoxide in COPD: Importance of Sex

    Chest, Vol. 160, Núm. 2, pp. 481-490

2020

  1. Bronchoscopist's perception of the quality of the single-use bronchoscope (Ambu aScope4™) in selected bronchoscopies: a multicenter study in 21 Spanish pulmonology services

    Respiratory Research, Vol. 21, Núm. 1

  2. Comment on: Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: Data from the NEREA Registry: Reply

    Rheumatology (United Kingdom)

  3. Cross-speciality geriatrics: A health-care challenge for the 21st century

    Revista Espanola de Geriatria y Gerontologia, Vol. 55, Núm. 2, pp. 84-97

  4. Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: Data from the NEREA Registry

    Rheumatology (United Kingdom), Vol. 59, Núm. 8, pp. 2099-2108

2018

  1. Changes and Clinical Consequences of Smoking Cessation in Patients With COPD: A Prospective Analysis From the CHAIN Cohort

    Chest, Vol. 154, Núm. 2, pp. 274-285

2017

  1. Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD

    The European respiratory journal, Vol. 50, Núm. 5

  2. Situación actual de la rehabilitación respiratoria en los hospitales de la Comunidad de Madrid

    Revista de Patologia Respiratoria, Vol. 20, Núm. 4, pp. 109-115

  3. Variability in adherence to clinical practice guidelines and recommendations in COPD outpatients: A multi-level, cross-sectional analysis of the EPOCONSUL study

    Respiratory Research, Vol. 18, Núm. 1

2016

  1. BRCA2 gene mutations and coagulation-associated biomarkers

    Thrombosis and Haemostasis, Vol. 115, Núm. 2, pp. 415-423

  2. Defining the asthma-COPD overlap syndrome in a COPD Cohort

    Chest, Vol. 149, Núm. 1, pp. 45-52